Peroutka S J
Department of Neurology, Stanford University, CA 94305.
Neuropharmacology. 1992 Jul;31(7):609-13. doi: 10.1016/0028-3908(92)90138-f.
The nomenclature system used to characterize 5-hydroxytryptamine receptor subtypes remains controversial. To date, the majority of nomenclature systems have been on the differential pharmacological properties of the receptors. However, the availability of molecular biological data allows for a nomenclature system based on the structural properties of the receptors. The evolutionary relationships between the known G protein-coupled 5-HT receptor subtypes were determined by a phylogenetic tree analysis. The data indicate that 2 major classes of G protein-coupled 5-HT receptors have evolved. Each of the 2 branches differentiate into additional 5-HT receptor subtypes. The most recent branching of 5-HT receptor subtypes occurs at the level of individual species. These data also indicate that the degree of structural similarity (e.g. 93% identify between human and rat 5-HT1B receptors) does not necessarily correlate with pharmacological similarity. Phylogenetic tree analysis allows for a nomenclature framework that can be easily expanded to incorporate additional 5-HT receptor subtypes that have yet to be identified.
用于描述5-羟色胺受体亚型的命名系统仍存在争议。迄今为止,大多数命名系统都是基于受体的不同药理学特性。然而,分子生物学数据的可用性使得基于受体结构特性的命名系统成为可能。通过系统发育树分析确定了已知G蛋白偶联5-羟色胺受体亚型之间的进化关系。数据表明,G蛋白偶联5-羟色胺受体已进化出两大类。这两个分支中的每一个又分化为其他5-羟色胺受体亚型。5-羟色胺受体亚型的最新分支发生在单个物种的层面。这些数据还表明,结构相似程度(例如,人类和大鼠5-HT1B受体之间93%的一致性)不一定与药理学相似性相关。系统发育树分析提供了一个命名框架,可以很容易地扩展以纳入尚未确定的其他5-羟色胺受体亚型。